Quick Answer
GILEAD SCIENCES, INC. reported Total Assets of $59.02 billion for fiscal year 2025.
GILEAD SCIENCES, INC. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $59.02B | +0.0% |
| 2024 | $58.99B | -5.0% |
| 2023 | $62.12B | -1.7% |
| 2022 | $63.17B | -7.0% |
| 2021 | $67.95B | -0.7% |
| 2020 | $68.41B | +11.0% |
| 2019 | $61.63B | -3.2% |
| 2018 | $63.67B | -9.4% |
| 2017 | $70.28B | +23.4% |
| 2016 | $56.98B | +10.2% |
| 2015 | $51.72B | +49.2% |
| 2014 | $34.66B | +53.5% |
| 2013 | $22.58B | +6.3% |
| 2012 | $21.24B | +22.8% |
| 2011 | $17.30B | +49.3% |
| 2010 | $11.59B | +19.5% |
| 2009 | $9.70B | +39.8% |
| 2008 | $6.94B | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $58.53B | +7.4% | +5.0% |
| June 30, 2025 | $55.72B | +4.0% | -1.3% |
| March 31, 2025 | $56.43B | +0.3% | -4.3% |
| December 31, 2024 | $58.99B | -5.0% | +8.2% |
| September 30, 2024 | $54.52B | -12.6% | +1.8% |
| June 30, 2024 | $53.58B | -14.0% | -4.8% |
| March 31, 2024 | $56.29B | -9.0% | -9.4% |
| December 31, 2023 | $62.12B | -1.7% | -0.4% |
- GILEAD SCIENCES, INC. showed an increase of +0.0% in Total Assets compared to the prior fiscal year.
- Over the 2008–2025 period, GILEAD SCIENCES, INC.’s total assets has grown by 750.9% (from $6.94 billion to $59.02 billion).
- The most recent figure is from GILEAD SCIENCES, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: